Daniel G Welch - Net Worth and Insider Trading

Daniel G Welch Net Worth

The estimated net worth of Daniel G Welch is at least $4 Million dollars as of 2024-04-28. Daniel G Welch is the Director of Seagen Inc and owns about 17,519 shares of Seagen Inc (SGEN) stock worth over $4 Million. Daniel G Welch is also the Director of Intercept Pharmaceuticals Inc and owns about 3,108 shares of Intercept Pharmaceuticals Inc (ICPT) stock worth over $59,052. Details can be seen in Daniel G Welch's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel G Welch has not made any transactions after 2023-08-28 and currently still holds the listed stock(s).

Transaction Summary of Daniel G Welch

To

Daniel G Welch Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel G Welch owns 7 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Intercept Pharmaceuticals Inc (ICPT) , and Seagen Inc (SGEN) among others .

Click here to see the complete history of Daniel G Welch’s form 4 insider trades.

Insider Ownership Summary of Daniel G Welch

Ticker Comapny Transaction Date Type of Owner
RARE Ultragenyx Pharmaceutical Inc 2015-04-08 director
ICPT Intercept Pharmaceuticals Inc 2020-05-28 director
SGEN Seagen Inc 2023-08-28 director
AVXS AveXis Inc 2018-05-15 director
CORI Corium International Inc 2014-04-02 director
NUVB Nuvation Bio Inc 2021-02-10 director
GPCR Structure Therapeutics Inc 2023-02-02 director

Daniel G Welch Latest Holdings Summary

Daniel G Welch currently owns a total of 2 stocks. Among these stocks, Daniel G Welch owns 17,519 shares of Seagen Inc (SGEN) as of August 28, 2023, with a value of $4 Million and a weighting of 98.55%. Daniel G Welch also owns 3,108 shares of Intercept Pharmaceuticals Inc (ICPT) as of July 31, 2017, with a value of $59,052 and a weighting of 1.45%.

Latest Holdings of Daniel G Welch

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SGEN Seagen Inc 2023-08-28 17,519 228.74 4,007,296
ICPT Intercept Pharmaceuticals Inc 2017-07-31 3,108 19.00 59,052

Holding Weightings of Daniel G Welch


Daniel G Welch Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel G Welch has made a total of 8 transactions in Seagen Inc (SGEN) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Seagen Inc is the sale of 4,925 shares on August 28, 2023, which brought Daniel G Welch around $1 Million.

According to the SEC Form 4 filings, Daniel G Welch has made a total of 0 transactions in Intercept Pharmaceuticals Inc (ICPT) over the past 5 years. The most-recent trade in Intercept Pharmaceuticals Inc is the sale of 602 shares on July 31, 2017, which brought Daniel G Welch around $74,606.

Insider Trading History of Daniel G Welch

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel G Welch Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniel G Welch Ownership Network

Ownership Network List of Daniel G Welch

No Data

Ownership Network Relation of Daniel G Welch


Daniel G Welch Owned Company Details

What does Ultragenyx Pharmaceutical Inc do?

Who are the key executives at Ultragenyx Pharmaceutical Inc?

Daniel G Welch is the director of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include EVP and Chief Medical Officer Eric Crombez , CBO & Senior Vice President Thomas Richard Kassberg , and EVP and General Counsel Karah Herdman Parschauer .

Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary

Over the past 18 months, Daniel G Welch made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 5,605 shares made by Theodore Alan Huizenga , a net sale of 127,435 shares made by Emil D Kakkis , and a net sale of 54,366 shares made by Thomas Richard Kassberg .

In summary, during the past 3 months, insiders sold 69,133 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 69,133 shares. During the past 18 months, 243,293 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 243,293 shares.

Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ultragenyx Pharmaceutical Inc Insider Transactions

No Available Data

Daniel G Welch Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel G Welch. You might contact Daniel G Welch via mailing address: 4611 University Dr, 4 University Place, Durham Nc 27707.

Discussions on Daniel G Welch

No discussions yet.